![Edward Conner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Edward Conner
Technik-/Wissenschafts-/F&E-Leiter bei
JADE BIOSCIENCES, INC.
Vermögen: 2 Mio $ am 31.05.2026
Profil
Edward R.
Conner is currently Chief Medical Officer at Jade Biosciences, Inc. since 2026.
Formerly, Dr. Conner was Chief Medical Officer at Third Harmonic Bio, Inc. from 2022 to 2025, Chief Medical Officer at Ardelyx, Inc. in 2025, Chief Medical Officer at Locanabio, Inc. from 2021 to 2022, Division Head-Gene Therapy Medical & Development at Astellas Gene Therapies, Inc. from 2019 to 2021, Independent Director at Imara, Inc. from 2020 to 2023, Chief Medical Officer & Senior Vice President at Sangamo Therapeutics, Inc. from 2016 to 2019, Vice President-Clinical Development at Ultragenyx Pharmaceutical, Inc. from 2015 to 2016, Senior Medical Director at BioMarin Pharmaceutical, Inc. from 2013 to 2014, and Medical Director at Genentech, Inc. from 2008 to 2013.
Education includes undergraduate studies at Duke University and a doctorate from The University of California, San Francisco.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ARDELYX, INC. 0,12 % | 01.08.2025 | 302.260 ( 0,12 % ) | 2 Mio $ | 31.05.2026 |
Aktive Positionen von Edward Conner
| Unternehmen | Position | Beginn |
|---|---|---|
| JADE BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 22.04.2026 |
Ehemalige bekannte Positionen von Edward Conner
| Unternehmen | Position | Ende |
|---|---|---|
| ARDELYX, INC. | Technik-/Wissenschafts-/F&E-Leiter | 31.12.2025 |
| THIRD HARMONIC BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 31.07.2025 |
| IMARA | Direktor/Vorstandsmitglied | 24.02.2023 |
Locanabio, Inc.
 Locanabio, Inc. Packaged SoftwareTechnology Services Develops and operates software platform for addressing a wide spectrum of human genetic diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2022 |
| AUDENTES THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Edward Conner
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
54
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardelyx, Inc.
 Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
Imara, Inc.
 Imara, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes novel therapeutics for patients with sickle cell disease | Health Technology |
Locanabio, Inc.
Locanabio, Inc. Packaged SoftwareTechnology Services Develops and operates software platform for addressing a wide spectrum of human genetic diseases | Technology Services |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Third Harmonic Bio, Inc.
 Third Harmonic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of allergic and immune diseases and disorders | Health Technology |
